FOCP, EHS to drive cancer detection efforts
The agreement, signed by Dr Shamsa Majid Lootah, Director of the Public Health Department at EHS, and Aisha Al Mulla, Director of FOCP, underscores FOCP's ongoing commitment to working collaboratively with national healthcare institutions to benefit the wider community. It sets out a framework for expanding early detection programmes and strengthening both financial and emotional assistance for patients.
EHS has long been a strategic partner of FOCP, with both organisations having previously joined forces on cancer awareness initiatives.
The renewed partnership provides a platform to broaden the scope of collaboration and align efforts in support of the UAE's national strategy to curb cancer prevalence and lessen its impact on patients and their families.
Commenting on the partnership, Dr. Essam Al Zarouni, Acting Executive Director of the Medical Services Sector at EHS, affirmed that the MoU represents an advanced integration model among national sectors pursuing the country's healthcare goals. This collaboration aligns with the National Strategy for Wellbeing 2031 objectives and the UAE Centennial 2071. For her part, Dr Shamsa Lootah highlighted that EHS is committed to expanding strategic partnerships with key community stakeholders to support its focus on disease prevention and early detection, particularly for cancer.
Through ongoing awareness programmes and initiatives, EHS aims to raise public awareness, encourage healthy lifestyles and improve early diagnosis and treatment, in line with its commitment to comprehensive healthcare.
Aisha Al Mulla, Director of FOCP, said: 'The new partnership with EHS represents a significant step forward in our shared mission to raise community awareness of cancer and strengthen patient support systems. It builds on a longstanding collaboration between us.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Gulf Today
02-08-2025
- Gulf Today
FOCP's Dhs3.6m in assistance helps over 136 cancer patients
The Friends of Cancer Patients (FOCP) has concluded its second quarterly board meeting of 2025, with discussions focused on reviewing performance for the first five months of the year, financial expenditures, upcoming awareness campaigns, as well as support initiatives. The Board also approved the annual report, reviewed preparations for the October Pink Caravan campaign, and ratified Q2 financial disbursements, which totalled Dhs3,637,159 and supported 136 patients across various nationalities and age groups. The meeting was chaired by Sawsan Jafar, Chairman of the Board and Founding Member; and attended by Sheikha Lubna Al Qasimi, Vice President and Founding Member; Sheikha Aisha Khalid Al Qasimi, Board Secretary; and board members including Dr. Moza Al Shehhi, Khawla Al Serkal, Dr. Abdalla Al Zarooni, Ibrahim Al Khayal, and Najla Al Midfa; as well as Aisha Al Mulla, Director of FOCP. Sustainable charitable model During proceedings, Sawsan Jafar affirmed the board's unified commitment to advancing FOCP's mission under the guidance of Her Highness Sheikha Jawaher Bint Mohammed Al Qasimi, Wife of the Ruler of Sharjah and Founder and Patron of FOCP. She said: 'Our strategic direction remains firmly rooted in social responsibility and generosity, ensuring a lasting and sustainable model of humanitarian action. The board is committed to a holistic management approach that balances strategic planning with continuous evaluation, enhancing FOCP's long-term impact.' Holistic patient support Emphasising the growing focus on strengthening partnerships to broaden the scope of support medically, psychologically, and socially, Dr. Abdalla Al Zarooni said: 'We are developing impactful initiatives tailored to meet the diverse needs of cancer patients and ensure a safe, empowering environment that sustains hope and emotional resilience throughout their treatment journey.' Enabling access to important positions In line with its ongoing efforts to advance regional strategies for noncommunicable diseases (NCDs), FOCP announced the appointment of Majed Mohamed to the Board of Directors of the Eastern Mediterranean Noncommunicable Disease Alliance (NCDA). In this dual capacity, he serves both as an external public health specialist and representative of FOCP. Commenting on this appointment, he said: 'This role allows me to contribute to regional health strategies while representing an organization that has long been at the forefront of cancer and NCD advocacy. It is an honour to amplify FOCP's mission on a broader regional platform.' Strategic partnerships and international presence During the second quarter of 2025, FOCP signed an MoU with the Emirates Health Services (EHS) to bolster early detection, community awareness, and financial and emotional support for cancer patients, in line with national healthcare goals. On the international stage, FOCP participated in the 25th IUHPE World Conference on Health Promotion which was held in the region for the first time in May 2025, where they contributed to a panel discussion on equality and innovation in cancer care and hosted patient-centric activities designed to empower survivors and their families. Comprehensive care and advocacy As part of its integrated care approach, FOCP delivered eight patient support events this year with 12 partners, reaching 279 patients and survivors. The organisation also engaged in five local and international advocacy platforms, attracting 225 attendees and producing seven strategic reports demonstrating FOCP's influence on health and community policy. Additionally, FOCP joined the UAE Oncology Society's cancer survivor graduation ceremony at the Museum of the Future, celebrating resilient recovery journeys. Earlier this year, reflecting themes of heartfelt caring and generosity during the Holy Month of Ramadan, Friends of Cancer Patients (FOCP) demonstrated the power of unity and community support by organising a series of compassionate events across the UAE. Partnering with philanthropic individuals, compassionate companies, and government entities, FOCP's efforts aim to uplift cancer patients, survivors, and their families, embodying the sentiment of Ramadan through acts of kindness and solidarity. On March 7, FOCP commenced its Ramadan event series with a supportive Iftar gathering hosted in collaboration with TIME Grand Plaza Hotel (Dubai) for 50 children battling cancer, their parents, and also for survivors. This touching tribute timed with International Women's Day, also celebrated and honoured the resilience of mothers, whose strength often forms the foundational support of their children's brave journeys.
Sharjah 24
01-08-2025
- Sharjah 24
FOCP reviews achievements in Q2 board meeting
The meeting was chaired by Her Excellency Sawsan Jafar, Chairman of the Board and Founding Member; and attended by Her Excellency Sheikha Lubna Al Qasimi, Vice President and Founding Member; Her Excellency Sheikha Aisha Khalid Al Qasimi, Board Secretary; and board members including Her Excellency Dr. Moza Al Shehhi, Her Excellency Khawla Al Serkal, His Excellency Dr. Abdalla Al Zarooni, His Excellency Ibrahim Al Khayal, and Her Excellency Najla Al Midfa; as well as Aisha Al Mulla, Director of FOCP. Sustainable charitable model During proceedings, Her Excellency Sawsan Jafar affirmed the board's unified commitment to advancing FOCP's mission under the guidance of Her Highness Sheikha Jawaher bint Mohammed Al Qasimi, Wife of the Ruler of Sharjah and Founder and Patron of FOCP. She said: 'Our strategic direction remains firmly rooted in social responsibility and generosity, ensuring a lasting and sustainable model of humanitarian action. The board is committed to a holistic management approach that balances strategic planning with continuous evaluation, enhancing FOCP's long-term impact.' Holistic patient support Emphasising the growing focus on strengthening partnerships to broaden the scope of support medically, psychologically, and socially; His Excellency Dr. Abdalla Al Zarooni said: 'We are developing impactful initiatives tailored to meet the diverse needs of cancer patients and ensure a safe, empowering environment that sustains hope and emotional resilience throughout their treatment journey.' Enabling access to important positions In line with its ongoing efforts to advance regional strategies for noncommunicable diseases (NCDs), FOCP announced the appointment of Majed Mohamed to the Board of Directors of the Eastern Mediterranean Noncommunicable Disease Alliance (NCDA). In this dual capacity, he serves both as an external public health specialist and representative of FOCP. Commenting on this appointment, he said: 'This role allows me to contribute to regional health strategies while representing an organization that has long been at the forefront of cancer and NCD advocacy. It is an honor to amplify FOCP's mission on a broader regional platform.' Strategic partnerships and international presence During the second quarter of 2025, FOCP signed an MoU with the Emirates Health Services (EHS) to bolster early detection, community awareness, and financial and emotional support for cancer patients, in line with national healthcare goals. On the international stage, FOCP participated in the 25th IUHPE World Conference on Health Promotion which was held in the region for the first time in May 2025, where they contributed to a panel discussion on equality and innovation in cancer care and hosted patient-centric activities designed to empower survivors and their families. Comprehensive care and advocacy As part of its integrated care approach, FOCP delivered eight patient support events this year with 12 partners, reaching 279 patients and survivors. The organisation also engaged in five local and international advocacy platforms, attracting 225 attendees and producing seven strategic reports demonstrating FOCP's influence on health and community policy. Additionally, FOCP joined the UAE Oncology Society's cancer survivor graduation ceremony at the Museum of the Future, celebrating resilient recovery journeys.
Hi Dubai
13-06-2025
- Hi Dubai
Dubai Health Authority Approves Yas Healthcare to Build UAE's First Proton Therapy Centre
Dubai is set to become home to the UAE's first proton therapy centre, as the Dubai Health Authority (DHA) has granted initial approval to Yas Healthcare, a subsidiary of Das Holding, for the groundbreaking project. The facility, slated to begin construction in early 2026 and open by late 2028, marks a major step forward in the country's fight against cancer. The Yas Proton Therapy Centre will introduce one of the most advanced forms of cancer treatment to the region. Proton therapy delivers highly targeted radiation to tumours, significantly reducing damage to surrounding healthy tissue. This precision makes it particularly effective for paediatric cancers and tumours near vital organs. 'This centre will offer world-class, patient-focused care, reinforcing Dubai's position as a hub for advanced medical innovation,' said Dr. Alawi Alsheikh-Ali, Director-General of DHA. He highlighted the project's alignment with Dubai's long-term health strategies, including the Dubai Economic Agenda D33 and the National Strategy for Wellbeing 2031. Developed in collaboration with the National Cancer Centre Singapore (NCCS), a leader in oncology, the project will benefit from global clinical and technical expertise. NCCS will serve as the project consultant throughout the design and implementation phases. Dr. Mohamad Zaki of Yas Healthcare emphasized the growing need for such treatment, citing rising cancer rates and the advantages of proton therapy in reducing long-term side effects. Once operational, the centre will eliminate the need for regional patients to travel abroad for this specialised care, supporting Dubai's medical tourism goals and improving access to cutting-edge cancer treatment across the GCC. News Source: Emirates News Agency
